Mount Hope Mining is preparing for a 9 December ASX listing, focusing on copper and gold exploration in the Cobar Basin, with five high-priority targets and a strategy based on recent geological insights.
Copyright 2024 – Finance News Network
Source: Finance News Network
05 Feb 2021 - Centuria Office REIT (ASX:COF) Fund Manager Grant Nichols discusses 1H21 highlights, the market conditions for leasing, and the outlook and trends for office markets.
Read More08 Jan 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker, talks about the company’s plans to develop Anagrelide, for the treatment of cancer, and to commercialise its lead product ZolpiMist worldwide.
Read More01 Mar 2021 - Nutritional Growth Solutions Limited (ASX:NGS) Chairman Brian Leedman talks about the science behind the company's nutritional supplement formulae for children, which are designed to promote height and weight.
Read More30 May 2022 - Fred Pye, CEO and Chairman of digital asset manager 3iQ, discusses the future of cryptocurrencies and the launch of two crypto ETFs in Australia based on Ethereum and Bitcoin.
Read More25 Jul 2024 - Alex Dorsch - CEO & Managing Director - Chalice Mining (ASX:CHN) is advancing the Gonneville Project—a major 2020 discovery in Western Australia with critical metals like platinum, nickel, and copper—towards development. The project boasts a tier-1 Mineral Resource Estimate, significant land in the new West Yilgarn Ni-Cu-PGE Province, and has earned multiple awards, including the 2023 Thayer Lindsley Award.
Read More24 Jun 2020 - Immutep (ASX:IMM) CEO, Marc Voigt provides an update on its clinical trials including metastatic breast cancer (MBC), its global leadership under Chief Scientist and Medical Officer, Professor Frederic Triebel, and the growing interest by big pharma in immuno-therapies.
Read More25 Mar 2024 - Clean TeQ Water (ASX:CNQ) CEO Peter Voigt provides an overview of the company, discussing solutions for the global scarcity in water.
Read More02 Oct 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly discusses the company's prefeasibility study, operational costs and development timeline.
Read More26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
Read More06 Sep 2023 - GBM Resources Limited (ASX:GBZ) Managing Director Peter Rohner provides an update on the company's projects, discussing the JV with Newcrest Mining (ASX:NCM) and recent divestments.
Read More
